Just In
- 5 hrs ago Summer Fashion: Your Bollywood Style White Outfits Guide To Keep It Cool And Chic
- 6 hrs ago Sonam Kapoor Stuns In A Huisang Zhang Skirt Set, A Skirt-Top Style Guide From The OG Fashionista!
- 9 hrs ago Thrissur Pooram 2024: Date, Time, History, Significance, And Celebrations Related To Kerala's Rich Traditions
- 13 hrs ago Daily Horoscope, 19 April 2024: Gemini Will Have A Controversial Day In Terms Of Love
Don't Miss
- Movies Exclusive! Shreyas Talpade On His Health After Heart Attack, "If Your Health Is Fine Then..."
- Finance Gold Prices In US: Yellow Metal Rates Surge Amid Escalating Tensions In Middle East; Hit Record High
- News There's No INDIA Alliance In West Bengal, Says Mamata Banerjee, Alleges Congress Joined Hands With BJP
- Sports PAK vs NZ 2nd T20I: Will Rain play spoilsport in Rawalpindi on Saturday?
- Automobiles Suzuki Swift Hatchback Scores 4 Star Safety Rating At JNCAP – ADAS, New Engine & More
- Education NLSIU Announces the Rajiv K. Luthra Foundation Grant
- Technology Dell Introduces AI-Powered Laptops and Mobile Workstations for Enterprises in India
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
WHO Approves First Malaria Vaccine Mosquirix After Trials In Africa: Know More About It
The World Health Organization approved the first malaria vaccine on Wednesday, October 6, 2021 after years of testing in three African countries, aiming to save the lives of thousands of children on the continent each year. WHO Director-General Tedros Adhamon Ghebreyesus called the endorsement by two expert advisory groups of the UN health agency "an historic moment."
What Do We Know About The Malaria Vaccine?
Mosquirix, as the malaria vaccine is known, was first created by British pharmaceutical company GlaxoSmithKline (GSK) in 1987. "This is a vaccine developed in Africa by African scientists and we're very proud," said the WHO Director-General. "Using this vaccine in addition to existing tools to prevent malaria could save tens of thousands of young lives each year," he added.
WHO researched its effectiveness on over 800,000 children in Ghana, Kenya and Malawi since 2019.
The parasitic disease is passed on by mosquitoes with nets and sprays being the only protections from infection so far.
Despite its approval for use, it is only 30% effective at preventing severe cases, requires four doses and the protection it gives fades after a few months. Although side effects are rare, they could include fever and convulsions.
But with malaria killing 400,000 people each year in Africa, many of them children under five, out of a total of 200 million cases, scientists are enthused by its approval. This death toll is marginally higher than that caused by COVID-19 in Africa throughout 2019.
GSK is now looking for additional funding for the vaccination drive, with the company aiming to produce 15 million doses a year at a 5% mark-up over manufacturing costs.
What Have Scientists Said About It?
"Today's recommendation offers a glimmer of hope for the continent, which shoulders the heaviest burden of the disease. We expect many more African children to be protected from malaria and grow into healthy adults," WHO's Africa Director Dr Matshidiso Moeti said.
"This is a huge step forward,'' said Julian Rayner, director of the Cambridge Institute for Medical Research, who was not part of the WHO decision. "It's an imperfect vaccine, but it will still stop hundreds of thousands of children from dying," he said.
Dr Alejandro Cravioto, who headed the WHO group that vetted the jab, said it was difficult to design the shots. "We are not yet in reach of a highly efficacious vaccine but what we have now is a vaccine that can be deployed and that is safe," said Cravioto.
Azra Ghani, chair of infectious diseases at Imperial College London, said: "A 30% reduction will save a lot of lives and will save mothers (from) bringing in their children to health centers and swamping the health system."
Another malaria vaccine being developed by Oxford University showed up to 77% efficacy during a year-long early trial with 450 children.
Source: DW News
- healthEris Variant: WHO Alarms New Covid Wave; Should India Be Concerned About This Pandemic
- healthDiet Coke Declared Cancerous By WHO: 5 Important Points; What To Drink Instead
- healthWorld Food Safety Day: WHO Ten Keys To Ensuring Food Safety
- healthEar-Safety Habits By WHO: Did You Know Sharing Your Earphones Is A Big No-No?
- healthFive Cities Recognised For Public Health Achievements: Bangalore Makes The List
- healthWHO Reports 90% Of The World's Population Is Immune To COVID
- healthWorld Pneumonia Day 2022: History, Significance And Theme
- disorders cureWHO Publishes First-Ever List Of Fungal Pathogens: What You Should Know
- healthNew WHO Initiative Aims To Stop The Spread Of Malaria Vectors: What You Should Know
- disorders cureWHO Publishes First Ebola Treatment Guideline
- wellnessHealth Minister Dr Mansukh Mandaviya Addresses 75th Session Of World Health Assembly In Geneva
- wellnessWHO Director-General Dr Tedros Ghebreyesus On Three-Day Gujarat Visit